ArticleJTO clinical and research reportsPublished
Phase II Trial of Regorafenib and Oral Methotrexate in Previously Treated Advanced KRAS-Mutant NSCLC
Regional connection
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Temple Health. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- JTO clinical and research reports
- Published
- Topic
- Clinical care
- Subject terms
- Methotrexate; ctDNA; Targeted Therapy; Kras Mutation; Regorafenib
- PubMed ID
- 39624248
- PubMed Central ID
- PMC11609302
- Open access
- Yes, open
- Added to directory
- Source checked